Related by context. Frequent words. (Click for all words.) 73 commercializing therapeutic 73 Adeona Pharmaceuticals Inc. 72 Inc. Nasdaq NEXM 71 Urigen Pharmaceuticals Inc. 70 Connetics Corporation 69 Inc. Nasdaq SUPG 69 Nasdaq CRXL 69 topically delivered 69 NASDAQ SNTA biopharmaceutical 69 NASDAQ CRXL 69 BioMarin develops 68 Crucell NV Euronext 68 immunologic diseases 68 Amgen discovers develops 68 OTCBB NEOP diversified 68 SANUWAVE Health 68 Amgen discovers develops manufactures 67 EPIX Pharmaceuticals Inc. 67 Callisto Pharmaceuticals Inc. 67 MultiCell Technologies 67 Ceragenix Pharmaceuticals Inc. 67 commercializes innovative biopharmaceuticals 67 novel antibody therapeutics 67 Novelos Therapeutics Inc. 67 Nasdaq ENMD 67 ImmuneRegen BioSciences Inc. 66 Company Nasdaq PRGO 66 gets USFDA nod 66 Synergy Pharmaceuticals 66 Regado Biosciences 66 HAYWARD Calif. BUSINESS WIRE 66 commercializes biotherapeutics 66 Healthnostics Inc. 66 Vitae Pharmaceuticals 66 Agios Pharmaceuticals 66 Inc. NASDAQ TRGT 66 NovaBay Pharmaceuticals 65 Barrier Therapeutics Inc. 65 Fresenius Kabi AG 65 fibrosis IPF 65 WATERTOWN Mass. BUSINESS WIRE 65 NYSE Amex RNN 65 HepaLife Technologies Inc. 65 Archemix Corp. 65 Adnexus Therapeutics 65 including nutritionals devices 65 Transdel Pharmaceuticals Inc. 65 Initiates Phase II 65 hepatitis C lupus 65 therapies Biogen Idec 65 CardioVascular BioTherapeutics Inc. 65 topical anti infective 65 addressing idiopathic pulmonary 65 Promedior 65 bio therapeutics 65 CA Somaxon Pharmaceuticals 65 CureDM 65 EKR Therapeutics 65 Exploit collaboration 64 Therapeutic Competitors 64 cystic fibrosis inflammation autoimmune 64 Nasdaq ATEC 64 ImmunoCellular Therapeutics Ltd. 64 Transcept Pharmaceuticals 64 Nutra Pharma Corporation 64 TSX VENTURE ZMS FRANKFURT 64 MorphoSys AG FSE MOR 64 Inc. NASDAQ MBLX 64 Nasdaq ASTM 64 immunotherapeutics 64 Adherex Technologies Inc. 64 please visit http:/www.supergen.com 64 Inc. Nasdaq IMGN 64 Roche SIX RO 64 China Aoxing Pharmaceutical 64 Cerus Corporation 64 Merck discovers develops 64 ARCA biopharma Inc. 64 Bayer HealthCare subsidiary 64 markets therapeutic ultrasonic 64 NASDAQ SLP 64 www.vivus.com 64 non personalized allogeneic 64 Genaera Corporation 64 Omeros Corporation 64 Receives Orphan Drug Designation 64 Salmedix 64 Metabasis Therapeutics Inc. 64 Inc. NASDAQ QLTI 64 LEXINGTON Mass. BUSINESS WIRE 63 Inc Therapeutic Competitors 63 Advancing Wellness 63 therapeutic monoclonal antibodies 63 Vasomedical Inc. 63 Hyperion Therapeutics 63 GAITHERSBURG Md. BUSINESS WIRE 63 Helix BioMedix Inc. 63 See BioWorld Today 63 By Neil Osterweil 63 developing Zerenex TM 63 immuno inflammatory diseases